Skip to main content
SpringerLink
Log in

The Many Molecular Mysteries of Melanoma

  • Protocol
Melanoma Techniques and Protocols

Part of the book series: Methods in Molecular Medicine ((MIMM,volume 61))

  • 478 Accesses

Abstract

Melanoma of the skin is one of the most rapidly increasing malignancies in both young and old patients (1,2). Not only is the incidence increasing, but the number of annual deaths from melanoma is also on the rise worldwide (3). In the United States, melanoma will be diagnosed in 43,000 new patients each year and be responsible for 7300 deaths (1 death every 72 min). The capacity of melanoma to develop in young patients is reflected by the rather alarming statistic that it has become one of the top causes of death in both men and women between the ages of 25 and 40 (3). Indeed, among Caucasian females, melanoma is the leading cause of death from malignancy between the ages of 25 and 29 (3). It is expected that by 2002, 1 in 70 Americans will develop melanoma during their lifetime (2). Also, melanoma is second only to adult leukemia as the leader in the number of potential years of life lost, which is significantly greater than for patients with cervical, breast, and colon malignancies (4). Despite the frequent presence of melanoma and major associated health problems around the globe, only recently have clinicians and laboratory-based researchers begun to unravel some of the molecular mysteries of melanoma (5,6). The purpose of Melanoma: Methods and Protocols, published as part of the Methods in Molecular Medicine™ series, is to provide an up-to-date review of the many advances that have taken place during the past several years involving the pathophysiology, diagnosis, genetic analysis, and treatment approaches for patients with melanoma (7).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Hall, H. I., Miller, D. R., Rogers, J. D., and Bewerse, B. B. (1999) Update on the incidence and mortality from melanoma in the United States. J. Am. Acad. Dermatol. 40, 35–42.

    Article  PubMed  CAS  Google Scholar 

  2. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. (1997) Cancer statistics. Cancer Clin. 47, 5–27.

    Article  CAS  Google Scholar 

  3. Dennis, L. K. (1999). Analysis of the melanoma epidemic, both apparent and real. Arch. Dermatol. 135, 275–280.

    Article  PubMed  CAS  Google Scholar 

  4. Albert, V. A., Koh, H. K., Geller, A. C., Miller, D. R., Prout, M. N., and Lew, R. A. (1990) Years of potential life cost: another indicator of the impact of cutaneous malignant melanoma on society. J. Am. Acad. Dermatol. 23, 308–310.

    Article  PubMed  CAS  Google Scholar 

  5. Kamb, A. (1996) Human melanoma genetics. J. Invest. Dermatol. 1, 177–182.

    CAS  Google Scholar 

  6. Sauter, E. R. and Herlyn, M. (1998). Molecular biology of human melanoma development and progression. Mol. Carcinogenesis 23, 132–143.

    Article  CAS  Google Scholar 

  7. Rosenberg, S. A. (1992) Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer. J. Clin. Oncol. 10, 180–199.

    PubMed  CAS  Google Scholar 

  8. Cockerell, C. J. (1993) Atypical melanocytic nevi, in Cutaneous Medicine and Surgery (Arndt, K. A., Robinson, J. K., LeBoit, P., Weintraub, B., eds.), WB Saunders, New York, pp. 1571–1575.

    Google Scholar 

  9. Morton, D. L., Dartyan, D. G., Wanck, L. A., et al. ( 1993) Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark Level and Breslow thickness. Cancer 71, 3737–3743.

    Article  PubMed  CAS  Google Scholar 

  10. Balch, C. M., Murad, T. M., Soong, S.-J., et al. ( 1978) A multifactorial analysis of melanoma: prognostic histopathological factors comparing Clark’s and Breslow’s staging methods. Am. Surg. 188, 732–742.

    CAS  Google Scholar 

  11. Gromet, M. A., Epstein, W. L., and Blois, M. S. (1978) The regressing thin melanoma: a distinctive lesion with metastatic potential. Cancer 42, 2282–2292.

    Article  PubMed  CAS  Google Scholar 

  12. Trau, H., Rigel, D. S., and Harris, M. N. (1983) Metastases of thin melanomas. Cancer 553–556.

    Google Scholar 

  13. Slinghuff, C. L., Vollmer, R. T., Reintgen, D. S., et al. (1988) Lethal “thin” malignant melanoma identifying patients at risk. Ann. Surg. 208, 150–161.

    Article  Google Scholar 

  14. Villmer, C., Barilly, C., LeDaussal, V., et al. ( 1996) Thin melanomas with unusual aggressive behavior: a report of nine cases. J. Am. Acad. Dermatol. 34, 439–444.

    Article  Google Scholar 

  15. Prade, M., Sancho-Garnier, H., Cesarini, J. P., et al. ( 1996) Difficulties encountered in the application of Clark classification and the Breslow thickness measurements in cutaneous malignant melanoma. Int. J. Cancer 26, 159–163.

    Article  Google Scholar 

  16. Goldsmith, L. A., Askin, F. B., Chang, A. E., et al. ( 1992) Diagnosis and treatment of early melanoma. NIH consensus development panel on early melanoma. JAMA 268, 1314–1319.

    Article  Google Scholar 

  17. Shivers, S. C., Wang, X., Weigua, L., et al. ( 1994) Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 280, 768–774.

    Google Scholar 

  18. Wong, J. M., Cagle, L. A., and Morton, D. L. (1991) Lymphatic drainage of skin to a sentinel node in a feline model. Am. Surg. 214, 637–641.

    CAS  Google Scholar 

  19. Morena, J. G., Cruse, C. M., and Fisher, R. (1992) Detection of hematogenous micrometastases in patients with prostate cancer. Cancer Res. 52, 6110–6112.

    Google Scholar 

  20. Naguchi, S., Aihara, T., Motomura, K., et al. ( 1996) Detection of breast cancer micrometastases in axillary nodes by means of reverse transcriptase-polymerase chain reaction. Am. J. Pathol. 148, 649–656.

    Google Scholar 

  21. Wang, X., Heller, R., Van Voorhis, N., et al. (1994) Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann. Surg. 220, 768–774.

    Article  PubMed  CAS  Google Scholar 

  22. Alanka, T., Rosenberg, M., and Saksela, O. (1999) FGF expression allows nevus cells to survive in three-dimensional collagen gels under conditions that induce apoptosis in normal human melanonocytes. J. Invest. Dermatol. 113, 111–116.

    Article  Google Scholar 

  23. Nickoloff, B. J. (1999) Is FGF a life-saver for nevus cells? J. Invest. Dermatol. 113, 2.

    Google Scholar 

  24. Rodeck, U., Melber, K., Kath, R., and Herlyn, M. (1991) Consitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J. Invest. Dermatol. 97, 20–26.

    Article  PubMed  CAS  Google Scholar 

  25. Seline, P. C., Norris, D. A., Horikawa, T., Fujita, M., Middleton, M. H., and Morelli, J. G. (1996) Expression of E-and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet irradiation. J. Invest. Dermatol. 106, 1320–1324.

    Article  PubMed  CAS  Google Scholar 

  26. Wick, M. R., Swanson, P. E., and Rocamura, A. (1988) Recognition of malignant melanoma by monoclonal antibody HMB-45: an immunohistochemical study of 200 paraffin-embedded cutaneous tumors. J. Cutan. Pathol. 15, 201–207.

    Article  PubMed  CAS  Google Scholar 

  27. Ordanez, N. G., Ji, X. L., and Hickey, R. C. (1988) Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma. Am. J. Clin. Pathol. 90, 385-390.

    Google Scholar 

  28. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalini, S. L., Miki, T., and Rosenburg, S. A. (1994) Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumors. Proc. Natl. Acad. Sci. USA 91, 3515–3519.

    Article  PubMed  CAS  Google Scholar 

  29. Kerbel, R. S., Kobayashi, H., Graham, C. H., and Lu, C. (1996) Analysis and significance of the malignant “eclipse” during the progression of primary cutaneous human melanomas. J. Invest. Dermatol. 1, 183–197.

    CAS  Google Scholar 

  30. Blanchard, A.P. (1996) Sequence to array: probing the genome’s secrets. Nat. Biotech. 14, 649.

    Article  Google Scholar 

  31. Duggan, D. J., Bittner, M., Chen, Y., Meltzer, P., and Trent, J. M. (1999) Expression profiling using cDNA microarrays. Nat. Genet. 21(Suppl 1), 10–19.

    Article  PubMed  CAS  Google Scholar 

  32. Brown, P. O. and Botstein, D. (1999) Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21(Suppl.), 33–37.

    Article  PubMed  CAS  Google Scholar 

  33. Nelson, P. S., Ng, W., Schummer, M., True, L. D., Liu, A. Y., Bumgarner, R. E., Fergusson, C., Dimak, A., and Hood, L. (1998) An expressed-sequence-tag data base of the human prostate: sequence analysis of 1168 cDNA clones. Genomics 47, 12–25.

    Article  PubMed  CAS  Google Scholar 

  34. Golub, T. R., Slonim, D. K., Tamayoo, P., et al. ( 1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531–537.

    Article  PubMed  CAS  Google Scholar 

  35. Kammula, U. S., Lee, K.-H., Riker, A., et al. ( 1999) Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens. J. Immunol. 163, 6867–6879.

    PubMed  CAS  Google Scholar 

  36. Clark, E. A., Golub, T. R., Landen, E. S., and Hynes, R. D. (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532–535.

    Article  PubMed  CAS  Google Scholar 

  37. Bittner, M., Meltzer, P., Chen, Y., et al. ( 2000) Moleuclar classification of cutaneous malignant melanoma by gene expression: shifting from a continuous spectrum to distinct biologic entities. Nature 406, 536–540.

    Article  PubMed  CAS  Google Scholar 

  38. Wang, E., Miller, L., Ohnmacht, G. A., Liu, E., and Marincola, F. M. (2000) High fidelity amplification for gene profiling using cDNA microarrays. Nature Biotech. 17, 457–459.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Skin Cancer Research Laboratories, Department of Pathology, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL

    Brian J. Nickoloff

Authors
  1. Brian J. Nickoloff
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Loyola University Medical Center, Maywood, IL

    Brian J. Nickoloff MD,PhD

  2. Institute for Systems Biology, Seattle, WA

    Leroy Hood MD,PhD (President and Director) (President and Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Humana Press Inc.

About this protocol

Cite this protocol

Nickoloff, B.J. (2001). The Many Molecular Mysteries of Melanoma. In: Nickoloff, B.J., Hood, L. (eds) Melanoma Techniques and Protocols. Methods in Molecular Medicine, vol 61. Humana Press. https://doi.org/10.1385/1-59259-145-0:3

Download citation

  • DOI: https://doi.org/10.1385/1-59259-145-0:3

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-684-0

  • Online ISBN: 978-1-59259-145-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation